0000899243-20-033475.txt : 20201211
0000899243-20-033475.hdr.sgml : 20201211
20201211061643
ACCESSION NUMBER: 0000899243-20-033475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201210
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baeuerle Patrick
CENTRAL INDEX KEY: 0001362054
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38811
FILM NUMBER: 201382205
MAIL ADDRESS:
STREET 1: WOLDPROMENADE 18C
CITY: GAUTING
STATE: 2M
ZIP: 82131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001750019
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474152751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-5200
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-10
0
0001750019
TCR2 THERAPEUTICS INC.
TCRR
0001362054
Baeuerle Patrick
TCR2 THERAPEUTICS INC.
100 BINNEY STREET
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
350786
I
By APAK Solutions GmbH
Stock Option (Right to Buy)
31.83
2020-12-10
4
A
0
12100
0.00
A
2030-12-09
Common Stock
12100
12100
D
The reported securities are owned directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.
/s/ Margaret Siegel as Attorney-in-Fact
2020-12-10